Business briefs: AbbVie cuts sales staff; docs say patients share health data; Stonefly founder dies

Share this article:

AbbVie is shaking off more than its parent company—a report from Bloomberg indicates the company is also shedding sales staff. An inside source told Bloomberg that the layoffs will be in the hundreds and will hit the reps which front heart drugs, such as cholesterol meds TriCor and Triplix, which started ceding ground to generics last fall. The news comes soon after the announcement that patent losses were also causing Lilly to cut its sales staff. In Lilly's case, the cuts were among reps in its neuroscience, musculoskeletal, cardiovascular and men's health divisions.

Seven in ten physicians said at least one of their patients was sharing health measurement data with them, though that data might be getting lost in translation, as their methods of sharing it are a bit low-tech, a Manhattan Research survey has found. The top methods of sharing cited by docs were handwritten notes and printouts, the firm's Taking the Pulse survey of 2,950 US physicians found. “Self-tracking is already a part of the care paradigm and its prevalence is going to accelerate rapidly as digital connection, payment reform, and outcome focused delivery makes advances,” said James Avallone, Director of Physician Research at Manhattan Research. “We are seeing physician attitudes toward self-tracking aligning with policy, which is encouraging for all stakeholders involved.”

Stonefly Communications Group founder and ex-CEO John Racik has died at 52 following a long battle with cancer. Racik, who took over BlueDiesel in 2002 before forming Stonefly, was "one of the sharpest strategic minds in our business," said Joe Daily, president of GSW, which merged with BlueDiesel earlier this year. "He had remarkable drive and uncompromising expectations for everything he touched, which led to countless relationships in the business and success for the agency. The only thing bigger than John's personality was the passion he had for our clients' success." He is survived by his wife and two children. 

 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.